DeepFDR: A Deep Learning-based False Discovery Rate Control Method for Neuroimaging Data

Voxel-based multiple testing is widely used in neuroimaging data analysis. Traditional false discovery rate (FDR) control methods often ignore the spatial dependence among the voxel-based tests and thus suffer from substantial loss of testing power. While recent spatial FDR control methods have emerged, their validity and optimality remain questionable when handling the complex spatial dependencies of the brain. Concurrently, deep learning methods have revolutionized image segmentation, a task closely related to voxel-based multiple testing. In this paper, we propose DeepFDR, a novel spatial FDR control method that leverages unsupervised deep learning-based image segmentation to address the voxel-based multiple testing problem. Numerical studies, including comprehensive simulations and Alzheimer's disease FDG-PET image analysis, demonstrate DeepFDR's superiority over existing methods. DeepFDR not only excels in FDR control and effectively diminishes the false nondiscovery rate, but also boasts exceptional computational efficiency highly suited for tackling large-scale neuroimaging data.

BiTr-Unet: a CNN-Transformer Combined Network for MRI Brain Tumor Segmentation

Convolutional neural networks (CNNs) have recently achieved remarkable success in automatically identifying organs or lesions on 3D medical images. Meanwhile, vision transformer networks have exhibited exceptional performance in 2D image classification tasks. Compared with CNNs, transformer networks have an obvious advantage of extracting long-range features due to their self-attention algorithm. Therefore, in this paper we present a CNN-Transformer combined model called BiTr-Unet for brain tumor segmentation on multi-modal MRI scans. The proposed BiTr-Unet achieves good performance on the BraTS 2021 validation dataset with mean Dice score 0.9076, 0.8392 and 0.8231, and mean Hausdorff distance 4.5322, 13.4592 and 14.9963 for the whole tumor, tumor core, and enhancing tumor, respectively.